NCT07076836
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- West China Hospital Chengdu, Sichuan, China
Clinical trial condition
Immune Checkpoint Blockade
Explore clinical trials studying Immune Checkpoint Blockade. Study availability and eligibility vary by location and protocol.
5 public trials
2 recruiting studies
Immune Checkpoint Blockade trial results
NCT07071103
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Drug Resistance, +17 more
- Locations
-
- Cancer Hospital, Shantou University Medical College Shantou, Guangdong, China
Not yet recruiting
SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma
NCT06538935
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
Not specified
NCT06076135
- Conditions
- Immune Checkpoint Blockade, Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, +6 more
- Locations
-
- Cancer Hospital, Shantou University Medical College Shantou, Guangdong, China
NCT04997850
- Conditions
- Hepatocellular Carcinoma Non-resectable, Immune Checkpoint Blockade, Transarterial Chemoembolization, +1 more
- Locations
-
- West China Hospital of Sichuan University Chengdu, Sichuan, China